Status:
UNKNOWN
Platelets Function and Cardiovascular Events in Patients With End Stage Renal Disease
Lead Sponsor:
Assaf-Harofeh Medical Center
Conditions:
End Stage Renal Disease
Cardiovascular Disease
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this study is to perform a prospective evaluation regarding the relationship between platelets function and cardiovascular events in patients with ESRD. The study will include 100-200 ...
Detailed Description
Background Platelets play an important role in cardiovascular disease both in the pathogenesis of atherosclerosis and in the development of acute thrombotic events. Their importance in coronary diseas...
Eligibility Criteria
Inclusion
- The study will include patients with end stage renal disease, age 18 years or older, treated in the nephrology division of Assaf Harofeh medical center.
Exclusion
- Patients will be excluded if their platelets count will be lower then 50,000 cu/mm, if they have known hematologic malignancies, other solid malignancy with life expectancy of less then 1 year or if they are treated with Warfarin (Comadin).
Key Trial Info
Start Date :
September 1 2006
Trial Type :
OBSERVATIONAL
End Date :
December 1 2007
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT00407368
Start Date
September 1 2006
End Date
December 1 2007
Last Update
December 5 2006
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Nephrology Division, Aassaf-Harofeh Medical Center
Ẕerifin, Israel, 70300